Effects of improving insulin sensitivity on nontraditional cardiovascular risk factors in patients with type 2 diabetes

被引:0
作者
Richard E. Pratley
机构
关键词
Metformin; Rosiglitazone; Leukocyte Count; Polycystic Ovary Syndrome; Troglitazone;
D O I
10.1007/s11892-003-0055-4
中图分类号
学科分类号
摘要
引用
收藏
页码:63 / 64
页数:1
相关论文
共 17 条
  • [1] Laakso M(1997)Epidemiology of macrovascular disease in diabetes Diabetes Rev 5 294-315
  • [2] Lehto S(2000)Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study Ann Intern Med 133 81-91
  • [3] Saito I(2000)Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 42-47
  • [4] Folsom AR(2001)C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 327-334
  • [5] Brancati FL(2002)Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes Diabetes Care 25 542-549
  • [6] Festa A(1998)Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells Circ Res 83 1097-1103
  • [7] D’Agostino R(undefined)undefined undefined undefined undefined-undefined
  • [8] Howard G(undefined)undefined undefined undefined undefined-undefined
  • [9] Pradhan AD(undefined)undefined undefined undefined undefined-undefined
  • [10] Manson JE(undefined)undefined undefined undefined undefined-undefined